Drugs / FAPI-74
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05442151 | May 2022 → Mar 2026 overdue | neoplasm | Tadashi Watabe | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FAPI-74 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05442151 ↗ |
| Modality | Diagnostic / imaging agent | “[18F]AlF-FAPI-74 is a positron emission tomography tracer with high selectivity for FAP” PMID 34420105 ↗ Aug 2021 |